Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

A new study published in Science by a team of scientists across five continents led by King Abdullah University of Science ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Over 10 days, the porcine liver produces bile and porcine albumin, maintains stable blood flow, and shows no signs of ...

Women have a higher proportion of key immune cells between puberty and menopause, which may be linked to the sex hormone ...

Although itolizumab did not improve response rates at Day 29 for patients with acute GVHD, the therapy showed significant ...

Durable complete response (CR) in a MCC patient treated with 15 mg/kg solnerstotug + cemiplimab. Patient continues on ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...